Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93,227,509
-
Total 13F shares
-
89,677,551
-
Share change
-
-1,676,174
-
Total reported value
-
$3,871,037,353
-
Put/Call ratio
-
150%
-
Price per share
-
$43.16
-
Number of holders
-
229
-
Value change
-
-$60,385,179
-
Number of buys
-
95
-
Number of sells
-
125
Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q4 2015
As of 31 Dec 2015,
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) was held by
229 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
89,677,551 shares.
The largest 10 holders included
BAILLIE GIFFORD & CO, Capital Research Global Investors, Capital World Investors, SCOPIA CAPITAL MANAGEMENT LP, VANGUARD GROUP INC, IRIDIAN ASSET MANAGEMENT LLC/CT, FMR LLC, BlackRock Fund Advisors, FIRST TRUST ADVISORS LP, and D. E. Shaw & Co., Inc..
This page lists
229
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.